Back to News
Market Impact: 0.15
RTI Researchers Introduce New Measure to Track Adverse Events Among Patients Starting Care at Opioid Treatment Programs
Source: PR Newswire
Healthcare & Biotech
A study examining 1,226 U.S. treatment programs found a median 90-day acute-care rate of 5% after opioid treatment began, with substantial variation across programs. The new measure tracks substance-use-related hospital visits; no financial or market implications are reported.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
More News
- J&J's potential 'game-changer' drug — plus, what Microsoft's mass buyouts mean
- Cramer: I asked some tech insiders what to buy. They surprisingly said this drug stock
- The excitement around Moderna’s cancer vaccine is cooling. Here’s why.
- Moderna CEO Sees Cancer Vaccines Working Beyond Melanoma
- Bottoms Says Georgia Needs Pause on New Data Centers
- Genmab shares jump 13% on colorectal cancer drug trial results